PECS-2 for Breast Surgery

NCT03117894 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm Female
Regional Anesthesia
Anesthesia
Regional Anesthesia Morbidity
Anesthesia Morbidity

Interventions

DRUG: Ropivacaine 5 mg/ml, 35 ml
DRUG: Remifentanil 50 microg/ml
DRUG: Betamethason 4 mg
DRUG: Paracetamol 1,5 g
DRUG: Propofol
DRUG: Arcoxia, 120 mg
DRUG: Ondansetron 4 mg
DRUG: Morphine

Sponsor

Umeå University